K. BATYRBEKOV ¹, A. GALIAKBAROVA ¹

1. Center of expert endoscopy and interventional radiology of the National Research Oncology Center, Astana, the Republic of Kazakhstan

DOI: https://www.doi.org/10.52532/2521-6414-2022-4-66-42-45

UDC: 616.329-002:072.1

Year: 2022 issure: 66 number: 4 pages: 42-45

Download PDF:

ABSTRACT

Relevance: Barrett’s esophagus (BE) is a special disease characterized by metaplasia of the flat epithelium of the esophagus. The main danger of esophageal epithelial metaplasia is the high probability of develop-ing a malignant neoplasm at the site of the lesion – esophageal adenocarcinoma or can-cer of the cardioesophageal zone.
The study aimed to: evaluate the clinical effectiveness of new BE endoscopic treat-ment methods for their subsequent implementation in wide practice throughout the Re-public of Kazakhstan.
Methods: This article presents cases of clinical use of argon plasma coagulation of dysplasia lesions less than 2.0 cm in two patients with Barrett’s esophagus and the use of loop resection of dysplasia lesions more than 2.0 cm in three patients with Barrett’s esophagus.
Results: All the presented cases have shown the effectiveness of applied treatment. Control morphological examination showed no signs of BE in the epithelium.
Conclusion: All the presented cases have shown the effectiveness of applied treatment. Control morphological examination showed no signs of BE in the epithelium.
Keywords: Barrett’s esophagus (BE), metaplasia, endoscopy, esophageal neoplasms, gastroesophageal reflux.

List of sources used:

1. Standards of Practice Committee, Wani S., Qumseya B., Sultan S., Agrawal D., Cjandrasekhara V., Harnke B., Kothari S., McCarter M., Shaukat A., Wanf A., Yang J., Dewitt J. Endoscopic eradication therapy for patients with Barrett’s esophagus-associated dysplasia and intramucosal cancer//Gastrointest. Endosc. – 2018. – Vol. 87(4). – P. 907-931.E9. https://doi.org/10.1016/j.gie.2017.10.011
2. Cholapranee A., Trinidade A.J. Challenges in Endoscopic Therapy of Dysplastic Barrett’s Esophagus // Curr. Treat. Opt. Gastroenterol. – 2019. – Vol. 17. – P. 32-47. https://doi.org/10.1007/s11938-019-00215-8
3. Ishihara R., Arima M., Iizuka T. Endoscopic submucosal dissection/endoscopic mucosal resection guidelines for esophageal cancer // Digest. Endosc. – 2020. – Vol. 32. – P. 452-493. https://doi.org/10.1111/den.13654
4. Sami S.S., Ravindran A., Kahn A. Timeline and location of recurrence following successful ablation in Barrett’s oesophagus: An international multicentre study // Gut. – 2019. – Vol. 68. – P. 1379-1385. https://doi.org/10.1136/gutjnl-2018-317513
5. Kolb J.M., Wani S. Barrett’s esophagus: Current standards in advanced imaging // Transl. Gastroenterol. Hepatol. – 2021. – Vol. 6. – P. 14. https://doi.org/10.21037/tgh.2020.02.10
6. Wronska E., Polkowski M., Orlowska J. Argon plasma coagulation for Barrett’s esophagus with low-grade dysplasia: A randomized trial with long-term follow-up on the impact of power setting and proton pump inhibitor dose // Endoscopy. – 2021. – Vol. 53. – P. 123-132. https://doi.org/10.1055/a-1203-5930